OS Therapies Incorporated
OS Therapies Incorporated (OSTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ostx · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.79
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.78 | ↓ 0.65% |
1-day model range: $1.76–$1.79. Peak: $1.79 (-0.65%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -28.8% |
| 2028 | $1 | -39.1% |
| 2029 | $1 | -43.5% |
| 2030 | $1 | -45.5% |
| 2031 | — | -46.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · OSTX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-19 | Lake Street | Maintains | Buy→Buy |
| 2026-04-30 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-04-08 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-03-27 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-03-09 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-02-05 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-01-05 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-12-15 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-12-09 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-12-05 | D. Boral Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on OS Therapies Incorporated (OSTX) stock. Of the recent 38 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover OSTX.
Analyst Recommendation Trends
OSTX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 95.5% YoY
Revenue Next Year
$33M
↑ 1134.0% YoY
EPS This Year
$-0.64
EPS Next Year
$-0.10
↓ 85.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast OSTX EPS of $-0.64 for the current fiscal year, based on estimates from 1 analysts. The OSTX revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The OSTX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OSTX price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The OSTX short-term stock prediction for tomorrow is $1.78 (-0.65%). The OSTX stock price prediction for 2027 estimates an average of $1. The OSTX stock prediction for 2030 projects a range of $1–$1.
OS Therapies Incorporated trades on AMEX under the ticker OSTX. The OSTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
OSTX forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month OSTX price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.79.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.